300
Participants
Start Date
July 28, 2017
Primary Completion Date
May 17, 2019
Study Completion Date
November 16, 2019
Triptorelin Pamoate PR 3-month
15mg/injection, administered as an intramuscular injection once every 12 weeks (a total of 2 injections).
Triptorelin Acetate PR 1-month
3.75mg/injection, administered as an intramuscular injection once every 4 weeks (a total of 6 injections)
Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing
Peking University First Hospital, Beijing
Chinese PLA General Hospital, Beijing
Peking University People's Hospital, Beijing
Beijing Friendship Hospital, Capital Medical University, Beijing
Peking University Third Hospital, Beijing
Peking Union Medical College Hospital, Beijing
The First Affiliated Hospital of Dalian Medical University, Dalian
Obstetrics and Gynaecology Hospital of Fudan University, Shanghai
Shanghai Tongji Hospital, Shanghai
Nanjing Maternity and Child Health Care Hospital, Nanjing
Zhongda Hospital, Southeast University, Nanjing
Northern Jiangsu People's Hospital, Yangzhou
Tianjin Medical University General Hospital, Tianjin
The Second Hospital of Tianjin Medical University, Tianjin
Women's Hospital, School of Medicine Zhejiang University, Hangzhou
Sir Run Run Shaw Hospital school of medicine, Zhejiang University, Hangzhou
The First Affiliated Hospital of Guangzhou Medical University, Guangzhou
Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou
The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou
The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning
Hainan General Hospital, Haikou
General Hospital of Ningxia Medical University, Yinchuan
The Second Hospital of Hebei Medical University, Shijiazhuang
Lead Sponsor
Ipsen
INDUSTRY